Dr. Meyer’s research focuses upon the differentiation of retinal ganglion cells from human pluripotent stem cells, including the derivation of glaucoma models through iPS cell reprogramming as well as Crispr/Cas9 gene editing.
Dr. Meyer’s research focuses upon the differentiation of retinal ganglion cells from human pluripotent stem cells, including the derivation of glaucoma models through iPS cell reprogramming as well as Crispr/Cas9 gene editing.